Language:

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-31 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0349-9 ;PMID: 30885279

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
Author: Wang, Feng‐Hua ; Shen, Lin ; Li, Jin ; Zhou, Zhi‐Wei ; Liang, Han ; Zhang, Xiao‐Tian ; Tang, Lei ; Xin, Yan ; Jin, Jing ; Zhang, Yu‐Jing ; Yuan, Xiang‐Lin ; Liu, Tian‐Shu ; Li, Guo‐Xin ; Wu, Qi ; Xu, Hui‐Mian ; Ji, Jia‐Fu ; Li, Yuan‐Fang ; Wang, Xin ; Yu, Shan ; Liu, Hao ; Guan, Wen‐Long ; Xu, Rui‐Hua
Subjects: Adjuvant ; Chemotherapy ; China ; Chinese Society of Clinical Oncology (CSCO) ; Clinical practice guidelines ; Diagnosis ; Gastric cancer ; Guideline and Consensus ; Humans ; Immunotherapy ; Medical diagnosis ; Medical Oncology ; Neoadjuvant ; Radiotherapy ; Societies, Medical ; Stomach cancer ; Stomach Neoplasms - diagnosis ; Stomach Neoplasms - therapy ; Surgery ; Targeted therapy
Is Part Of: Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-31
Description: China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non‐Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub‐specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence‐based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts’ consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow‐up visits for gastric cancer.
Publisher: London: BioMed Central
Language: English;Chinese
Identifier: ISSN: 2523-3548
EISSN: 2523-3548
DOI: 10.1186/s40880-019-0349-9
PMID: 30885279
Source: Open Access: DOAJ Directory of Open Access Journals
Open Access: PubMed Central
AUTh Library subscriptions: ProQuest Central
MEDLINE

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

Searching Remote Databases, Please Wait